Two methods of catalytic asymmetric synthesis of (S)-3,5-dibromophenylalanine are presented. One approach is to use asymmetric alkylation reaction starting from diphenylimine glycine tert-butyl ester and 3,5-dibromobenzyl bromide, with O-allyl-N-9-anthracene methyl bromide cinchonidine as phase-transfer catalyst, the (S)-3,5-dibromophenylalanine derivative was obtained (up to 94.9% ee). The optimized conditions of asymmetric phase transfer catalytic alkylation are explored. Another method is to employ asymmetric hydrogenation starting from 2-acetylamino-3-(3,5-dibromophenyl)acrylic acid with bis(1,5-cyclooctadiene)rhodium(I) trifluoromethanesulfonate and (R)-N-diphenylphosphino-N-methyl-1-[(S)-2-diphenyl-phosphino)ferrocenyl]ethylamine [(R)-methyl BoPhoz] as chiral catalyst. (S)-3,5-Dibromophenylalanine hydrochloride was obtained after hydrolysis. By Fmoc protection, Fmoc-(S)-3,5-dibromophenylalanine was obtained (up to 94.7% ee). By comparison of the two methods, the first one gives higher overall yield and a little bit better selectivity, and is more suitable for the synthesis of other chiral dihalo-substituented phenylalanine derivatives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.